Experts review latest advances in gene editing, antisense, and cell therapies for IRDs
In a programme that featured eight speakers, registrants attending the Euretina Session on inherited retinal disorders (IRDs) heard rapid-fire presentations on the status of innovative therapies for these diseases.
Experts review latest advances in gene editing, antisense, and cell therapies for IRDs Read More »